Skip to content
Certified ManufacturersFor manufacturers

Mason Vitamins, Inc.

Miami Lakes, FL, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

Mason Vitamins, Inc. is a dietary supplement manufacturer in Miami Lakes, FL, United States, certified to NSF/ANSI 455-2 GMP, with 1 manufacturing facility on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules, softgels and tablets.

Facilities listed
1
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (1)

  • Sentry Manufacturing, 15750 NW 59th Avenue, Miami Lakes, FL 33014, United States

    Facility operated as: Sentry Manufacturing

    • Dry Formulation
    • Encapsulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing

How Mason Vitamins, Inc. compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

FDA lists 2 recalls matching the name Mason Vitamins, Inc., as of .

  • Class III · Unlikely to cause health problems

    Reported

    Closed by FDA

    Product is sub-potent for Vitamins A, B12, B5 (Pantothenic acid), C, and E not meeting label claims.

    2 products, first listed: People's Choice Women's Daily Vitamins with Iron, 30 Tablets, Dietary Supplement

    See all 2 products
    • People's Choice Women's Daily Vitamins with Iron, 30 Tablets, Dietary Supplement
    • Healthy Sense Daily Multiple with Iron, Dietary Supplement, 20 Tablets
    openFDA record
  • Class III · Unlikely to cause health problems

    Reported

    Closed by FDA

    Product is mislabeled. Some of the Co Q 10 30 mg bottles were labeled with the incorrect label, Co Q 10 50 mg.

    Product: Coenzyme Q-10 50 mg label reads in part, "***Major***CO Q-10 50 MG***For healthy HEART & IMMUNE function***Promotes ENERGY in all Body Cells***Dietary Suppleme…

    Full product description
    • Coenzyme Q-10 50 mg label reads in part, "***Major***CO Q-10 50 MG***For healthy HEART & IMMUNE function***Promotes ENERGY in all Body Cells***Dietary Supplement 30 SOFTGELS***."
    openFDA record

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 7 food or dietary supplement inspections at facilities matching Mason Vitamins, Inc., from 2012 to 2026, as of . 5 found no objectionable conditions and 2 found conditions the firm was left to correct.

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miami Lakes, Florida

    Listed by FDA as Sentry Manufacturing, Inc.

    18 citations posted:

    • Hygienic practices (21 CFR 111.10(b))
    • Physical plant - clean and sanitary (21 CFR 111.15(b))
    • Equipment - design - appropriate and suitable (21 CFR 111.27(a))
    • Equipment - maintain - general (21 CFR 111.27(d))
    See all 18 citations
    • Hygienic practices (21 CFR 111.10(b))

      Your personnel did not use hygienic practices to the extent necessary to protect against contamination of components, dietary supplements, or contact surfaces.

    • Physical plant - clean and sanitary (21 CFR 111.15(b))

      You did not maintain your physical plant in a clean and sanitary condition and in repair sufficient to prevent components, dietary supplements, or contact surfaces from becoming contaminated.

    • Equipment - design - appropriate and suitable (21 CFR 111.27(a))

      You did not use equipment or utensils of appropriate design, of appropriate construction, of appropriate workmanship, suitable for its intended use, that can be adequately cleaned and that are properly maintained.

    • Equipment - maintain - general (21 CFR 111.27(d))

      You did not clean and sanitize equipment, utensils, and contact surfaces used to manufacture, package, label, or hold components or dietary supplements.

    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for identity, purity, strength, composition and limits on contamination.

    • Reserve sample - container-closure system (21 CFR 111.83(b))

      Your reserve sample of a dietary supplement was not held using the same container-closure system in which the packaged and labeled dietary supplement was distributed and did not consist of at least twice the quantity necessary for all tests or examinations to determine whether or not the dietary supplement meets product specifications.

    • Written procedures - establish; quality control operations (21 CFR 111.103)

      You did not establish written procedures for quality control operations.

    • Quality control - reject; specification not met (21 CFR 111.113(b)(2))

      Your quality control personnel did not reject a component when an established specification was not met.

    • Quality control - batch, product specifications (21 CFR 111.123(b)(2))

      Your quality control personnel approved and released for distribution a batch of dietary supplement that did not meet established product specifications.

    • Records - material review, disposition, follow-up (21 CFR 111.140(b)(3))

      Your documentation of your material review and disposition decision and follow-up did not include identification of the specific deviation or the unanticipated occurrence, a description of your investigation into the cause of the deviation from the specification or of the unanticipated occurrence, an evaluation of whether or not the deviation or unanticipated occurrence has resulted in or could lead to a failure to ensure the quality of the dietary supplement or a failure to package and label the dietary supplement as specified in the master manufacturing record, an explanation of what you did with the component, dietary supplement, packaging, or label and a scientifically valid reason for any reprocessing of a dietary supplement that is rejected or any treatment or in-process adjustment of a component that is rejected.

    • Master manufacturing record - record requirements (21 CFR 111.210)

      Your master manufacturing record did not include all required information.

    • Batch record - required information (21 CFR 111.260)

      Your batch production record did not include all required information.

    • Standard reference materials; criteria for selecting (21 CFR 111.315(d))

      You did not establish laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

    • Examination, testing; appropriate (21 CFR 111.320(a))

      You did not verify that the laboratory examination and testing methodologies are appropriate for their intended use.

    • Make and keep records - laboratory operations (21 CFR 111.325(b))

      You did not make and keep records for your laboratory operations.

    • Written procedures - follow; manufacturing operations (21 CFR 111.353)

      You did not follow written procedures for manufacturing operations.

    • Hold - in-process material; temperature, humidity, light (21 CFR 111.460(b))

      You did not hold in-process material under appropriate conditions of temperature, humidity, and light.

    FEI 1051353

  • No action indicated · No objectionable conditions found

    Inspected

    Miami Lakes, Florida

    Listed by FDA as Sentry Manufacturing, Inc.

    FEI 1051353

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miami Lakes, Florida

    2 citations posted:

    • Product - visually examine, identified (21 CFR 111.75(e))
    • Quality control operations - labeling; visual examinations (21 CFR 111.127(a))
    Full citation text
    • Product - visually examine, identified (21 CFR 111.75(e))

      You did not have documentation that the product you received for packaging or labeling is adequately identified and is consistent with your purchase order.

    • Quality control operations - labeling; visual examinations (21 CFR 111.127(a))

      Your quality control operations for labeling did not include reviewing the results of visual examinations and documentation to ensure that established specifications were met for products that you receive for labeling.

    FEI 1017766

  • No action indicated · No objectionable conditions found

    Inspected

    Miami Lakes, Florida

    Listed by FDA as Sentry Manufacturing, Inc.

    FEI 1051353

  • No action indicated · No objectionable conditions found

    Inspected

    Miami Lakes, Florida

    Listed by FDA as Sentry Manufacturing, Inc.

    FEI 1051353

Show all 7 inspections
  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miami Lakes, Florida

    Listed by FDA as Sentry Manufacturing, Inc.

    18 citations posted:

    • Hygienic practices (21 CFR 111.10(b))
    • Physical plant - clean and sanitary (21 CFR 111.15(b))
    • Equipment - design - appropriate and suitable (21 CFR 111.27(a))
    • Equipment - maintain - general (21 CFR 111.27(d))
    See all 18 citations
    • Hygienic practices (21 CFR 111.10(b))

      Your personnel did not use hygienic practices to the extent necessary to protect against contamination of components, dietary supplements, or contact surfaces.

    • Physical plant - clean and sanitary (21 CFR 111.15(b))

      You did not maintain your physical plant in a clean and sanitary condition and in repair sufficient to prevent components, dietary supplements, or contact surfaces from becoming contaminated.

    • Equipment - design - appropriate and suitable (21 CFR 111.27(a))

      You did not use equipment or utensils of appropriate design, of appropriate construction, of appropriate workmanship, suitable for its intended use, that can be adequately cleaned and that are properly maintained.

    • Equipment - maintain - general (21 CFR 111.27(d))

      You did not clean and sanitize equipment, utensils, and contact surfaces used to manufacture, package, label, or hold components or dietary supplements.

    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for identity, purity, strength, composition and limits on contamination.

    • Reserve sample - container-closure system (21 CFR 111.83(b))

      Your reserve sample of a dietary supplement was not held using the same container-closure system in which the packaged and labeled dietary supplement was distributed and did not consist of at least twice the quantity necessary for all tests or examinations to determine whether or not the dietary supplement meets product specifications.

    • Written procedures - establish; quality control operations (21 CFR 111.103)

      You did not establish written procedures for quality control operations.

    • Quality control - reject; specification not met (21 CFR 111.113(b)(2))

      Your quality control personnel did not reject a component when an established specification was not met.

    • Quality control - batch, product specifications (21 CFR 111.123(b)(2))

      Your quality control personnel approved and released for distribution a batch of dietary supplement that did not meet established product specifications.

    • Records - material review, disposition, follow-up (21 CFR 111.140(b)(3))

      Your documentation of your material review and disposition decision and follow-up did not include identification of the specific deviation or the unanticipated occurrence, a description of your investigation into the cause of the deviation from the specification or of the unanticipated occurrence, an evaluation of whether or not the deviation or unanticipated occurrence has resulted in or could lead to a failure to ensure the quality of the dietary supplement or a failure to package and label the dietary supplement as specified in the master manufacturing record, an explanation of what you did with the component, dietary supplement, packaging, or label and a scientifically valid reason for any reprocessing of a dietary supplement that is rejected or any treatment or in-process adjustment of a component that is rejected.

    • Master manufacturing record - record requirements (21 CFR 111.210)

      Your master manufacturing record did not include all required information.

    • Batch record - required information (21 CFR 111.260)

      Your batch production record did not include all required information.

    • Standard reference materials; criteria for selecting (21 CFR 111.315(d))

      You did not establish laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

    • Examination, testing; appropriate (21 CFR 111.320(a))

      You did not verify that the laboratory examination and testing methodologies are appropriate for their intended use.

    • Make and keep records - laboratory operations (21 CFR 111.325(b))

      You did not make and keep records for your laboratory operations.

    • Written procedures - follow; manufacturing operations (21 CFR 111.353)

      You did not follow written procedures for manufacturing operations.

    • Hold - in-process material; temperature, humidity, light (21 CFR 111.460(b))

      You did not hold in-process material under appropriate conditions of temperature, humidity, and light.

    FEI 1051353

  • No action indicated · No objectionable conditions found

    Inspected

    Miami Lakes, Florida

    Listed by FDA as Sentry Manufacturing, Inc.

    FEI 1051353

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miami Lakes, Florida

    2 citations posted:

    • Product - visually examine, identified (21 CFR 111.75(e))
    • Quality control operations - labeling; visual examinations (21 CFR 111.127(a))
    Full citation text
    • Product - visually examine, identified (21 CFR 111.75(e))

      You did not have documentation that the product you received for packaging or labeling is adequately identified and is consistent with your purchase order.

    • Quality control operations - labeling; visual examinations (21 CFR 111.127(a))

      Your quality control operations for labeling did not include reviewing the results of visual examinations and documentation to ensure that established specifications were met for products that you receive for labeling.

    FEI 1017766

  • No action indicated · No objectionable conditions found

    Inspected

    Miami Lakes, Florida

    Listed by FDA as Sentry Manufacturing, Inc.

    FEI 1051353

  • No action indicated · No objectionable conditions found

    Inspected

    Miami Lakes, Florida

    Listed by FDA as Sentry Manufacturing, Inc.

    FEI 1051353

  • No action indicated · No objectionable conditions found

    Inspected

    Miami Lakes, Florida

    Listed by FDA as Sentry Manufacturing, Inc.

    FEI 1051353

  • No action indicated · No objectionable conditions found

    Inspected

    Miami Lakes, Florida

    FEI 1017766

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • 1 facility address
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.

Ask about these in your quote request. How we verify

Other capsule manufacturers in the United States

  1. NSF lists 5 capsule facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a capsule facility in Centennial, CO

    Centennial, CO, United States5280smc.com

    • Capsules
    Operations:
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists a capsule facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a capsule facility in Ada, MI

    Ada, MI, United Statesamway.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists 2 capsule facilities, including one in Chandler, AZ

    Gilbert, AZ, United Statesadeptlifesciences.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    Operations:
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a capsule facility in Congers, NY

    Congers, NY, United Statesadhhealth.com

    • Capsules
    • Oils
    • Powders
    • Tablets
    Operations:
    • Coating
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026